In:
Archiv der Pharmazie, Wiley, Vol. 349, No. 7 ( 2016-07), p. 566-571
Kurzfassung:
A series of new N ‐(substituted)‐1‐methyl‐2,4‐dioxo‐1,2‐dihydroquinazoline‐3(4 H )‐carboxamides were designed, synthesized, and evaluated for their anticonvulsant activity. Most of the synthesized compounds exhibited potent anticonvulsant activities in the maximal electroshock (MES) and pentylenetetrazol (PTZ) test. The most promising compound 4c showed significant anticonvulsant activity with a protective index value of 3.58. The compounds 4a–c were also found to have encouraging anticonvulsant activity in the MES and PTZ screen when compared with the standard drugs, valproate and methaqualone. The same compounds were found to exhibit advanced anticonvulsant activity as well as lower neurotoxicity than the reference drugs.
Materialart:
Online-Ressource
ISSN:
0365-6233
,
1521-4184
DOI:
10.1002/ardp.201600024
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2016
ZDB Id:
1496815-0
SSG:
15,3
Permalink